Table 4 Multivariate risk prediction of SAD for mortality in patients with IPF
From: Small airway dysfunction in Chinese patients with idiopathic pulmonary fibrosis
Characteristics | HR (95% CI) | p |
|---|---|---|
SAD | 1.73 (1.02–2.92) | 0.040 |
Age | 0.99 (0.96–1.01) | 0.295 |
Males | 1.62 (0.83–3.16) | 0.158 |
FEV1/FVC, % | 1.02 (0.98–1.06) | 0.289 |
DLCO, % | 0.99 (0.97–1.00) | 0.036 |
Smoking | ||
Non-smoker | Reference | |
Current smoker | 0.87 (0.45–1.68) | 0.683 |
Former smoker | 0.79 (0.43–1.47) | 0.460 |
CCI | 1.11 (0.89–1.38) | 0.352 |
Hormone | 1.46 (0.82–2.62) | 0.199 |
Theophylline | 1.03 (0.57–1.87) | 0.910 |
N-acetylcysteine | 0.98 (0.61–1.58) | 0.933 |
Seretide | 1.01 (0.58–1.75) | 0.970 |